Loading page…
Healthcare
BioNTech SE achieves an AlphaScore of 41/100 in the Healthcare sector, priced at $96.96 with a market cap of $24.36 billion. Fundamentals include a gross margin of 77.64% and a net margin of -39.59%. A key strength is the strong gross margin of 77.64% and a high safety sub-score of 79 supported by a low debt-to-equity ratio of 0.02. A primary risk is the heavy net margin loss of -39.59% and negative return on equity of -9.30%. Evidence is limited to the provided snapshot data from 2026-10-11.
Written 11/10/2026, 00:33:30 UTC · Snapshot 11/10/2026